Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

08/11/2024 06:34

Nov 8 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             51.37               36.17            88.50    
                 (+42.0 pct)         (-1.8 pct)       (+22.8 pct) 
  Operating         19.58                5.51            20.80    
                (+255.2 pct)         (-32.8 pct)     (+118.6 pct) 
  Recurring         19.82                5.72            21.20    
                (+246.4 pct)         (-33.1 pct)     (+113.0 pct) 
  Net               14.29                4.07            14.20    
                (+251.2 pct)         (-31.8 pct)      (+76.9 pct) 
  EPS            377.23 yen          108.18 yen       374.93 yen  
  Ann Div                            150.00 yen       190.00 yen  
  -Q2 div        115.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T